Cost analysis of GER-induced asthma: A controlled study vs. atopic asthma of comparable severity

Respiratory Medicine

Volumn 101, Issue 8, 2007, Pages 1814-1820

  Dal Negro, Roberto Walter ^a   Turco, Paola ^a   Micheletto, Claudio ^a   Tognella, Silvia ^a   Bonadiman, Luca ^a   Guerriero, Massimo ^b   Sandri, Marco ^b  

^a Ospedale   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

Bronchial asthma; Cost of illness; Gastro oesophageal reflux; GER; Pharmaco economics

Indexed keywords

ANTITUSSIVE AGENT; ANXIOLYTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; HISTAMINE H2 RECEPTOR ANTAGONIST; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LONG ACTING DRUG; PROKINETIC AGENT; PROTON PUMP INHIBITOR; SALBUTAMOL; SHORT ACTING DRUG; THEOPHYLLINE;

ABSENTEEISM; ADULT; AGED; ALLERGIC ASTHMA; ARTICLE; ASTHMA; CONSULTATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; COST UTILITY ANALYSIS; DISEASE SEVERITY; DRUG COST; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH CARE NEED; HEALTH ECONOMICS; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PATIENT CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT;

ADULT; ASTHMA; COST OF ILLNESS; DRUG COSTS; FEMALE; GASTROESOPHAGEAL REFLUX; HUMANS; ITALY; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 34250662139     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2007.02.009     Document Type: Article

References (27)

1. Weiss K.B., Gergen P.J., and Hodgson T.A. An economic evaluation of asthma in the United States. N Engl J Med 326 (1992) 862-866
2. Dal Negro R., Pomari C., Micheletto C., and Turco P. Studi farmacoeconomici sull'asma in Italia. It J Chest Dis 47 (1992) 261-264
3. Lucioni C., Mazzi S., Serra G., and Vaghi A. Il costo sociale dell'asma nell'adulto, in Italia. Rass Pat App Resp 16 (2001) 90-103
4. Dal Negro R., Berto P., Tognella S., and Quareni L. Cost-of-illness of lung diseases in the TriVeneto region, Italy: the GOLD study. Monaldi Arch Chest Dis 57 (2002) 1-7
5. Sullivan S.D. Cost-effectiveness of drug interventions. Eur Respir Rev 6 (1996) 116-118
6. Cost-effectiveness of asthma management strategies. Eur Repir Rev 5 (1996) 1292-1294
7. Cerveri I., Zoia M.C., Bugiani M., Corsico A., Crosso A., Piccioni P., et al. Inadeguate antiasthma drug use in the north of Italy. Eur Respir J 10 (1997) 2761-2765
8. Godard P., Chanez P., Siraudin L., Nicolayannis N., and Duru G. Costs of asthma are correlated with severity: a 1-yr prospective study. Eur Respir Rev 19 (2002) 61-67
9. Briggs A.H., Bousquet J., Wallace M.V., Busse W.W., Clark T.J., Pedersen S.E., et al. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study. Allergy 61 5 (2006) 531-536
10. Bateman E.D., Bushey H.A., Bousquet J., Busse W.W., Clark T.J., Powels R.A., et al. Can guideline-defined asthma control be achieved? The gaining optimal asthma control study. Am J Respir Crit Care Med 170 8 (2004) 836-844
11. Adams R.J., Fuhlbrigge A., Guilbert T., Lozano P., and Martinez F. Inadequate use of asthma medication in the United States: results of the Asthma in America national population survey. J Allergy Clin Immunol 110 (2002) 58-64
12. Harding S.M., and Richter J.E. Gastroesophageal reflux disease and asthma. Semin Gastrointest Dis 3 (1992) 139-150
13. Irwin R.S., French C.L., and Curley F.J. Chronic cough due to gastroesophageal reflux: clinical, diagnostic and pathogenic aspects. Chest 104 (1993) 1511-1517
14. Pope II C.E. Acid reflux disorders. N Engl J Med 331 (1994) 656-660
15. Harding S.M., and Richter J.E. The role of gastroesophageal reflux in chronic cough and asthma. Chest 111 (1997) 1389-1402
16. Sontag S.J. Gastroesophageal reflux and asthma. Am J Med 103 (1997) 84s-90s
17. Dal Negro RW, Aubier M. Bronchial asthma and gastroesophageal reflux. In Chung F, Fabbri LM, editors. "Asthma", European respiratory monograph, vol. 8. p. 260-77.
18. Global strategy for Asthma. National Asthma Education and prevention Program Expert Panel report 2: guidelines for the diagnosis and management of asthma. Publication n° 97-4051. NHLBI/WHO Workshop. Bethesda, MD: National Institutes of Health; 2002.
19. Informatore farmaceutico. Masson Ed. Milano, 2004.
20. Ministero della Sanità. Tariffe Ambulatoriali Nazionali. Nomenclatore Tariffario delle prestazioni ambulatoriali, DM 22.07.1996, Gazzetta Ufficiale n° 216, 14.09.1996.
21. Ministero della Sanità. Aggiornamento delle tariffe delle prestazioni di assistenza ospedaliera. DM 14.12.1994, Gazzetta Ufficiale, Suppl. Ordinario, n° 209, 08.09.1997.
22. Banca d'Italia. Costo di una giornata di lavoro sui cittadini occupati, 2002.
23. Kjellen G., Tibbling L., and Wranne B. Bronchial obstruction after esophageal acid perfusion in asthmatic. Clin Physiol 1 (1981) 285-292
24. Ekstrom T., and Tibbling L. Esophageal acid perfusion, airway function, and symptoms in asthmatic patients with marked bronchial hyperreactivity. Chest 96 (1989) 995-998
25. Dal Negro R.W., Turati C., Micheletto C., Tognella S., and Pomari C. The enhancing of MCh response by acid drink is a sensitive and specific diagnostic test for assessing GER-induced asthma: a parallel group, controlled study vs normal subjects. Am J Respir Crit Care Med 165 (2002) A564
26. Field S.K. Underlying mechanisms of respiratory symptoms with esophageal acid when there is no evidence of airway response. Am J Med 111 (2001) 37s-40s
27. Dal Negro R., Pomari C., Micheletto C., Turco P., and Tognella S. Prevalence of gastro-oesophageal reflux in asthmatics: an Italian study. Ital J Gastroenterol Hepatol 31 (1999) 371-375